Clinical Trial: Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression

This study is no longer recruiting patients.

Sponsored by: National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by: National Center for Complementary and Alternative Medicine (NCCAM)

Purpose

The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.

Condition Treatment or Intervention Phase
HIV Infections
Diabetes
Depression
 Behavior: Yoga
Phase I

MedlinePlus related topics:  AIDS;   Depression;   Diabetes

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Official Title: Yoga, Health, and Meditation

Further Study Details: 

Expected Total Enrollment:  50

Study start: July 2004

In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.

Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.

Eligibility

Ages Eligible for Study:  14 Years   -   40 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria for Study 1 Participants:

  • Meet certain laboratory requirements

Inclusion Criteria for Study 2 Participants:

  • HIV infected
  • Able to walk at least 50% of the time

Inclusion Criteria for All Participants:

Exclusion Criteria for Study 2 Participants:

  • Require antiretroviral therapy

Location Information


India
      Swami Vivekananda Yoga Anusandhana Samsthana (SVAYSA), Bangalore,  India

Study chairs or principal investigators

Frederick M. Hecht, MD,  Principal Investigator,  UCSF Positive Health Program   

More Information

Study ID Numbers:  1-R21-AT001942-01
Record last reviewed:  January 2005
Last Updated:  January 24, 2005
Record first received:  August 26, 2004
ClinicalTrials.gov Identifier:  NCT00090506
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005